Astellas Receives Positive CHMP Opinion for XTANDITM (enzalutamide) for Patients with Metastatic Hormone-Sensitive Prostate Cancer Read more
Humanigen Reports Positive Phase 3 Topline Results Demonstrating That Lenzilumab Improves Survival Without Need for Mechanical Ventilation in Hospitalized Patients With COVID-19 Read more
Lilly, Vir Biotechnology and GSK announce positive topline data from the phase 2 BLAZE-4 trial evaluating bamlanivimab with VIR-7831 in low-risk adults with COVID-19 Read more
Johnson & Johnson Announces Advance Purchase Agreement with the African Vaccine Acquisition Trust for the Company’s COVID-19 Vaccine Candidate Read more
GSK and Vir Biotechnology announce submission of Emergency Use Authorization request to FDA for VIR-7831 for the early treatment of COVID-19 Read more
Invite from Jim Polarine and Geeta Singh, Co-Chairs to join Pharmaceutical Microbiology West Coast Virtual Conference Read more
Bright Peak Therapeutics Inc. and Ajinomoto Co., Inc. Enter into a Research Collaboration and License Agreement to Create Novel Immunocytokines Read more